DURECT Corporation
DRRX
$0.749
$0.03925.52%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/30/2025
-
TipRanks Financial Blog
3/28/2025
-
Insider Monkey
3/28/2025
-
Simply Wall St
3/28/2025
-
TipRanks Financial Blog
3/27/2025
-
GuruFocus
3/27/2025
-
GuruFocus
3/27/2025
-
SeekingAlpha.com: All News
3/27/2025
-
Seeking Alpha: Transcripts
3/27/2025
-
SeekingAlpha
3/26/2025
-
GuruFocus
3/26/2025
-
Zacks Investment Research
3/26/2025
-
GuruFocus
3/26/2025
-
TipRanks Financial Blog
3/26/2025
-
The Fly
3/26/2025
-
PR Newswire
3/25/2025
-
GuruFocus
3/20/2025
-
Zacks Investment Research
3/19/2025
-
GuruFocus
3/19/2025
-
PR Newswire
3/15/2025
-
Simply Wall St
2/23/2025
-
GuruFocus
2/21/2025
-
TipRanks Financial Blog
2/4/2025
-
GuruFocus
2/4/2025
-
PR Newswire
1/29/2025
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
408 777 1417
Address
10240 Bubb Road
Cupertino, CA 95014-4166
Cupertino, CA 95014-4166
Country
Year Founded
Business Description
Sector
DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company’s lead product larsucosterol (DUR-928), an endogenous, orally...
more
